Literature DB >> 11600459

Genomics at work: the global gene response to enteric bacteria.

D Kelly1, S Conway.   

Abstract

Mesh：

Year:  2001        PMID： 11600459      PMCID： PMC1728503          DOI： 10.1136/gut.49.5.612

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  12 in total

Review 1.  Bacterial regulation of intestinal immune responses.

Authors:  T T MacDonald; S Pettersson
Journal:  Inflamm Bowel Dis       Date:  2000-05       Impact factor: 5.325

2.  Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination.

Authors:  A S Neish; A T Gewirtz; H Zeng; A N Young; M E Hobert; V Karmali; A S Rao; J L Madara
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

3.  Identification of genes involved in mucosal defense and inflammation associated with normal enteric bacteria.

Authors:  H Ogawa; K Fukushima; I Sasaki; S Matsuno
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2000-09       Impact factor: 4.052

Review 4.  Inflammatory bowel disease: etiology and pathogenesis.

Authors:  C Fiocchi
Journal:  Gastroenterology       Date:  1998-07       Impact factor: 22.682

5.  A model of host-microbial interactions in an open mammalian ecosystem.

Authors:  L Bry; P G Falk; T Midtvedt; J I Gordon
Journal:  Science       Date:  1996-09-06       Impact factor: 47.728

6.  cDNA microarray analysis of adapting bowel after intestinal resection.

Authors:  L E Stern; C R Erwin; R A Falcone; F S Huang; C J Kemp; J L Williams; B W Warner
Journal:  J Pediatr Surg       Date:  2001-01       Impact factor: 2.545

7.  Initiation of assembly of the cell envelope barrier structure of stratified squamous epithelia.

Authors:  P M Steinert; L N Marekov
Journal:  Mol Biol Cell       Date:  1999-12       Impact factor: 4.138

8.  Segmented filamentous bacteria are potent stimuli of a physiologically normal state of the murine gut mucosal immune system.

Authors:  G L Talham; H Q Jiang; N A Bos; J J Cebra
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

9.  Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

Authors:  B J Rembacken; A M Snelling; P M Hawkey; D M Chalmers; A T Axon
Journal:  Lancet       Date:  1999-08-21       Impact factor: 79.321

10.  Effect of human C-reactive protein on chemokine and chemotactic factor-induced neutrophil chemotaxis and signaling.

Authors:  W Zhong; Q Zen; J Tebo; K Schlottmann; M Coggeshall; R F Mortensen
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422
View more
  5 in total

Review 1.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

Review 2.  Human nutrition and food research: opportunities and challenges in the post-genomic era.

Authors:  Susan J Fairweather-Tait
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-10-29       Impact factor: 6.237

3.  Towards the control of necrotic enteritis in broiler chickens with in-feed antibiotics phasing-out worldwide.

Authors:  Shawkat A M'Sadeq; Shubiao Wu; Robert A Swick; Mingan Choct
Journal:  Anim Nutr       Date:  2015-03-11

Review 4.  Implications of butyrate and its derivatives for gut health and animal production.

Authors:  Andrea Bedford; Joshua Gong
Journal:  Anim Nutr       Date:  2017-09-13

5.  Supplemental Bacillus subtilis DSM 29784 and enzymes, alone or in combination, as alternatives for antibiotics to improve growth performance, digestive enzyme activity, anti-oxidative status, immune response and the intestinal barrier of broiler chickens.

Authors:  Yuanyuan Wang; Chianning Heng; Xihong Zhou; Guangtian Cao; Lei Jiang; Jiangshui Wang; Kaixuan Li; Dianchun Wang; Xiuan Zhan
Journal:  Br J Nutr       Date:  2020-07-22       Impact factor: 3.718
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.